Abstract Background Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly referred to as polycystic ovary syndrome (PCOS), is an intricate endocrine disorder, defined by a constellation of hormonal, metabolic, and reproductive irregularities. Vitamin D deficiency and increased levels of interleukin-6 (IL-6) and int...
Roba Bdeir, Nour A. Al-Sawalha, H. Rawashdeh et al.· Annals medicus· 0 citations
Objective: Etoricoxib is a selective COX-2 inhibitor with poor aqueous solubility, which may limit its dissolution behavior and physicochemical performance. This study aimed to design, prepare, and optimize etoricoxib-loaded solid lipid nanoparticles (SLNs) to enhance the physicochemical properties and in vitro release...
Ahmed R. Gardouh, R. Malkawi, Ahmed Raja Alanezi· International Journal of App...· 0 citations
Objective: Paclitaxel is a widely used chemotherapeutic agent with extremely poor aqueous solubility (~0.3 µg/ml), which significantly limits its bioavailability and therapeutic efficacy. The present study aimed to develop and characterize paclitaxel-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles to enhance...
R. Malkawi· International Journal of App...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.